ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,497Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 457

$1.29M Total Retail Price of All Prescriptions

Rank: 28 out of 457

484 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 22,783 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 781 737 1 1
GABAPENTIN 773 711 2 15
LISINOPRIL 729 695 3 3
AMLODIPINE BESYLATE 725 695 4 4
METOPROLOL SUCCINATE 662 612 5 21
CRESTOR 643 593 6 9
LEVOTHYROXINE SODIUM 534 505 7 5
VOLTAREN 477 429 8 34
PAROXETINE HCL 431 428 9 68
SIMVASTATIN 428 416 10 2
ZOLPIDEM TARTRATE 418 413 11 13
FUROSEMIDE 418 404 11 10
LOSARTAN POTASSIUM 407 377 13 18
SERTRALINE HCL 374 357 14 57
METFORMIN HCL 358 330 15 6
ENALAPRIL MALEATE 350 288 16 35
CARVEDILOL 348 346 17 20
NEXIUM 346 282 18 12
GALANTAMINE HBR 337 337 19 194
IBUPROFEN 325 279 20 14
RANITIDINE HCL 311 310 21 17
ADVAIR DISKUS 297 258 22 27
ATENOLOL 291 271 23 11
CLOPIDOGREL 289 283 24 19
ALBUTEROL SULFATE 276 253 25 151
LIDODERM 249 195 26 31
HYDROCHLOROTHIAZIDE 248 239 27 8
LANTUS 244 222 28 56
POTASSIUM CHLORIDE 242 239 29 28
MUPIROCIN 238 229 30 91
PLAVIX 221 219 31 24
METOPROLOL TARTRATE 221 198 31 7
LOSARTAN-HYDROCHLOROTHIAZIDE 221 216 31 54
GLYBURIDE-METFORMIN HCL 209 181 R 34 70
DIOVAN 201 195 35 30
DONEPEZIL HCL 196 196 36 22
WARFARIN SODIUM 192 191 37 38
SINGULAIR 191 153 38 43
QUETIAPINE FUMARATE 175 173 39 109
DIGOXIN 168 157 40 69
NAMENDA 161 161 41 32
KETOCONAZOLE 160 143 42 92
SPIRIVA 160 151 42 101
LACTULOSE 155 138 44 78
TAMSULOSIN HCL 155 155 44 36
SYMBICORT 153 138 46 106
PREDNISONE 150 149 47 95
MIRTAZAPINE 150 150 47 100
MEGESTROL ACETATE 148 147 R 49 94
SILVER SULFADIAZINE 144 139 50 127
FAMOTIDINE 135 121 51 62
AZITHROMYCIN 130 117 52 44
ALENDRONATE SODIUM 130 117 52 16
DIOVAN HCT 129 118 54 51
CITALOPRAM HBR 128 122 55 45
BUPROPION HCL 123 114 56 368
METHOCARBAMOL 119 100 R 57 236
ALLOPURINOL 117 95 58 47
METOCLOPRAMIDE HCL 117 104 58 116
ESCITALOPRAM OXALATE 112 109 60 61
CIPROFLOXACIN HCL 112 108 60 71
THEOPHYLLINE ANHYDROUS 110 108 62 244
CLOTRIMAZOLE-BETAMETHASONE 107 77 63 60
DICYCLOMINE HCL 106 88 64 115
NITROGLYCERIN PATCH 104 100 65 157
MONTELUKAST SODIUM 103 92 66 86
SURE COMFORT 102 98 67 103
GLIPIZIDE 102 99 67 42
MELOXICAM 100 100 69 41
PROAIR HFA 97 69 70 66
INSULIN SYRINGE 91 77 71 79
IPRATROPIUM BROMIDE 91 91 71 216
CLONIDINE HCL 89 85 73 52
TRICOR 86 66 74 83
METRONIDAZOLE 83 80 75 319
SSD 82 73 76 158
NAPROXEN 82 67 76 65
GENTAMICIN SULFATE 81 75 78 404
LANTUS SOLOSTAR 78 59 79 121
COMBIVENT 77 61 80 133
CLOBETASOL PROPIONATE 76 68 81 125
FLUTICASONE PROPIONATE 74 64 82 40
DEXILANT 73 73 83 118
SUCRALFATE 72 67 84 163
PANTOPRAZOLE SODIUM 71 70 85 59
AMMONIUM LACTATE 71 71 85 82
LEVETIRACETAM 71 71 85 160
NOVOLIN 70-30 70 62 88 113
GLIMEPIRIDE 69 69 89 75
NYSTATIN-TRIAMCINOLONE 69 69 89 200
LEVOFLOXACIN 66 62 91 131
LANSOPRAZOLE 66 65 91 74
DICLOFENAC SODIUM 65 65 93 49
CILOSTAZOL 65 65 93 88
LYRICA 64 56 95 77
MECLIZINE HCL 64 64 95 55
TRAMADOL HCL 64 62 95 26
GLIPIZIDE ER 63 59 98 107
SEROQUEL 61 59 99 182
CARBIDOPA-LEVODOPA 60 60 100 128
ACTOS 59 57 101 105
PHENYTOIN SODIUM EXTENDED 59 59 101 171
GLIPIZIDE XL 57 54 103 159
NYSTATIN 56 54 104 234
BUMETANIDE 55 55 105 123
NIFEDIPINE ER 54 42 106 89
LEVEMIR 53 47 107 225
PEN NEEDLE 52 52 108 186
CEPHALEXIN 52 46 108 188
NOVOLIN R 52 49 108 147
AMLODIPINE BESYLATE-BENAZEPRIL 51 49 111 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.